TL32711
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TL32711, covering 2016-03-03 to 2021-05-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia [Phase 1, Phase 2]